Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
HLB LifeScience Logo
HLB LifeScience Growth Score
77
CB Rank
3809157
Heat Score
32
is a biopharmaceutical company that develops targeted anti-cancer drugs.
Founded
obfuscation
PublicPost-IPO Equity Gyeongju, Kyongsang-bukto, South Korea101-250 www.hlb-ls.com/
Biotechnology
Health Care
Life Science
Medical Device
Overview

HLB LifeScience
Growth Score
77
Heat Score
32

Growth Score77
-9 pts
in past quarter
Heat Score 32
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About HLB LifeScience

CB Rank
3809157
is a biopharmaceutical company that develops targeted anti-cancer drugs.
Founded
obfuscation
PublicPost-IPO Equity Gyeongju, Kyongsang-bukto, South Korea101-250 www.hlb-ls.com/
Biotechnology
Health Care
Life Science
Medical Device

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation

Details

Legal Name HLB LifeScience Co,. Ltd.
Also Known As 에이치엘비생명과학
Operating Status Active
Stock Symbol  KOSDAQ:067630
Company Type For Profit
About the Company
HLB LifeScience is a research-oriented global target anticancer drug development biotech company. They offer animal anti-cancer drug clinical and approval of pirotinib non-small cell lung cancer rare disease drug.
Phone Number 82-2-2627-6700
Contact Email hlbls@hlb-ls.com
Predictions & Insights

Products & Services

LIVTENCITY (Lenvatinib)
An oral multi-kinase inhibitor used for treating various cancers by inhibiting tumor growth and angiogenesis.
HLB Injection Syringe
A disposable syringe designed for single-use in medical and biopharmaceutical applications.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - HLB LifeScience Logo
Post-IPO Equity - HLB LifeScience
1
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 101-250
News

News and Press

News•Mar 21, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

245
-61.84%
 in past month

Active Website Tech Count

17HLB LifeScience is actively using 17 technologies for its website, according to BuiltWith. These include SSL by Default, HSTS, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is HLB LifeScience's headquarters? HLB LifeScience is located in Gyeongju, Kyongsang-bukto, South Korea.Who invested in HLB LifeScience? HLB LifeScience is funded by Alpenroute Asset Management.When was the last funding round for HLB LifeScience? HLB LifeScience closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are HLB LifeScience's competitors? Alternatives and possible competitors to HLB LifeScience may include Tyra Biosciences, Nerviano Medical Sciences, and  Eisai Korea.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6852caf 1)
|